Healthcare provider profile · identity verified

Larry Sharp, D.O.

Family Practice · PURCELL, OK · NPI 1306903315

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Liothyronine Sodium	Liothyronine Sodium	593	63
Losartan Potassium	Losartan Potassium	281	32
Synthroid	Levothyroxine Sodium	280	35
Omeprazole	Omeprazole	275	32
Lisinopril	Lisinopril	258	27
Rosuvastatin Calcium	Rosuvastatin Calcium	246	26
Amlodipine Besylate	Amlodipine Besylate	227	29
Atorvastatin Calcium	Atorvastatin Calcium	218	27
Gabapentin	Gabapentin	194	24
Albuterol Sulfate Hfa	Albuterol Sulfate	182	40
Fluticasone Propionate	Fluticasone Propionate	178	32
Montelukast Sodium	Montelukast Sodium	174	20
Diclofenac Sodium	Diclofenac Sodium	159	31
Clopidogrel	Clopidogrel Bisulfate	156	19
Tamsulosin Hcl	Tamsulosin Hcl	150	18
Celecoxib	Celecoxib	146	21
Hydrochlorothiazide	Hydrochlorothiazide	144	18
Metoprolol Tartrate	Metoprolol Tartrate	128	16
Furosemide	Furosemide	121	17
Pantoprazole Sodium	Pantoprazole Sodium	114	15
Ibuprofen	Ibuprofen	113	20
Duloxetine Hcl	Duloxetine Hcl	112	11
Potassium Chloride	Potassium Chloride	109	15
Ozempic	Semaglutide	106	11
Metformin Hcl	Metformin Hcl	90	12
Metoprolol Succinate	Metoprolol Succinate	87	11
Simvastatin	Simvastatin	82	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	81	13
Trazodone Hcl	Trazodone Hcl	81	12
Eliquis	Apixaban	71	12
Allopurinol	Allopurinol	63	11
Ondansetron Odt	Ondansetron	63	14
Buspirone Hcl	Buspirone Hcl	59	suppressed
Bupropion Hcl Sr	Bupropion Hcl	57	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	57	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	57	suppressed
Baclofen	Baclofen	56	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	56	suppressed
Ezetimibe	Ezetimibe	55	suppressed
Metformin Hcl Er	Metformin Hcl	54	suppressed
Atenolol	Atenolol	51	suppressed
Jardiance	Empagliflozin	50	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	49	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	47	suppressed
Clonidine Hcl	Clonidine Hcl	42	suppressed
Spironolactone	Spironolactone	41	suppressed
Meloxicam	Meloxicam	40	suppressed
Prednisone	Prednisone	40	35
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	39	suppressed
Estradiol	Estradiol	38	suppressed
Naproxen	Naproxen	37	suppressed
Spiriva Respimat	Tiotropium Bromide	37	suppressed
Sertraline Hcl	Sertraline Hcl	36	suppressed
Pregabalin	Pregabalin	35	suppressed
Solifenacin Succinate	Solifenacin Succinate	35	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Chlorthalidone	Chlorthalidone	33	suppressed
Carvedilol	Carvedilol	32	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	21
Nortriptyline Hcl	Nortriptyline Hcl	32	suppressed
Alendronate Sodium	Alendronate Sodium	31	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Propranolol Hcl	Propranolol Hcl	28	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	27	suppressed
Sucralfate	Sucralfate	27	suppressed
Acyclovir	Acyclovir	24	12
Aripiprazole	Aripiprazole	24	suppressed
Colestipol Hcl	Colestipol Hcl	24	suppressed
Lidocaine	Lidocaine	24	suppressed
Promethazine Hcl	Promethazine Hcl	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Alogliptin	Alogliptin Benzoate	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	21
Donepezil Hcl	Donepezil Hcl	23	suppressed
Famotidine	Famotidine	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Dulera	Mometasone/Formoterol	21	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Fluocinonide	Fluocinonide	20	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Topiramate	Topiramate	19	suppressed
Tramadol Hcl	Tramadol Hcl	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Azithromycin	Azithromycin	17	15
Clindamycin Phosphate	Clindamycin Phosphate	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Dupixent Pen	Dupilumab	14	suppressed
Finasteride	Finasteride	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Lubiprostone	Lubiprostone	12	suppressed
Ofev	Nintedanib Esylate	12	suppressed
Progesterone	Progesterone, Micronized	12	suppressed
Restasis	Cyclosporine	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Valsartan	Valsartan	12	suppressed
Betamethasone Valerate	Betamethasone Valerate	11	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Dupixent Syringe	Dupilumab	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Levemir Flextouch	Insulin Detemir	11	suppressed
Linzess	Linaclotide	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error